APACMed: Riding The Tailwind Of Health Care And Medtech Through The Pandemic And Beyond
COVID-19 has not put the brakes on the resurgence of health care, say Asia-based VC investors
VC investors and medtech strategists alike at APACMed’s 2020 virtual conference agreed that the challenges presented by COVID-19 have given healthtech a higher profile and accelerated the arrival of health system workflow improvements.
You may also be interested in...
The trend among device innovators to focus on diagnostic technologies that improve imaging, offer better visualization of tissues and avoid the need for biopsies is well noted by full-service law firm CMS. Its equIP program supports many start-ups incorporating AI into products and development processes.
Forum officially unveiled on 19 February to represent growing band of organizations designated against the UKCA mark.
Early diagnosis information is central to disease detection and will reduce treatment costs overall, says Nishan Sunthares, who heads the Association of British HealthTech Industries’ work on diagnostic technologies including IVDs.